Francis Kofi Amoo, MBBCh

https://medicine.duke.edu/faculty/francis-kofi-amoo-mbbch

Answer (A) is the mechanism of action of beta-blockers that are used sometimes during a thyroid storm diabetes type 1 gluten free diet purchase acarbose 25 mg mastercard. Answer (E) acting on thyroid hormone receptors, is the action of the substitution drugs, levothyroxine and liothyronine. In healthy persons, a dose of dexamethasone should suppress cortisol secretion the next morning and cortisol levels should be less than 5 mcg/dL. Congenital adrenal hyperplasia, chronic adrenal insufficiency, 11-hydroxylase deficiency, and pituitary insufficiency are all associated with decreased cortisol secretion. For the treatment of acute allergic reactions, the most effective regimens are those in which glucocorticoids are given in large doses initially and then gradually tapered over 5 to 7 days. This produces the most rapid improvement in symptoms while causing relatively little adrenal suppression. Fludrocortisone is approximately 100 times more potent as a mineralocorticoid than is cortisol and is the most potent mineralocorticoid available for clinical use. It acts to increase sodium retention and potassium excretion, thereby lowering serum potassium levels. Dexamethasone (A), triamcinolone (C), and prednisone (D) are potent glucocorticoids that would cause excessive glucocorticoid effects in a person already receiving adequate doses of hydrocortisone. Exogenous administration of glucocorticoid drugs causes feedback inhibition of the secretion of corticotropin-releasing hormone, corticotropin, cortisol, and cortisone. Secretion of the mineralocorticoid aldosterone is primarily under the influence of the reninangiotensin axis and is not suppressed greatly by exogenous glucocorticoid administration. Desonide is a low-potency topical corticosteroid appropriate for treating conditions of the face and eyes. Clobetasol (C) is a very-high-potency topical steroid, and fluocinonide (D) and desoximetasone (E) are high-potency topical steroids. Medium- to high-potency steroids are used on areas of the body with thicker skin than on the face and eyes. Raloxifene has antiestrogen effects on breast and uterine tissue but estrogenic effects on bone, and it is used to prevent osteoporosis. It is not indicated for the treatment of thromboembolism (A), menopausal symptoms (C) or endometriosis (D), or for contraception (E). Inclusion of a progestin will not prevent (A) breast cancer, (C) myocardial infarction, (D) stroke, or (E) elevated cholesterol levels. These drugs do not cause (A), breast tenderness, (B) alopecia, (C) glaucoma, or (D) deep vein thrombosis.

A study of women with low bone mass and preexisting vertebral fractures found that alendronate reduced new vertebral fractures by 47% over a 3-year period diabetes symptoms normal blood sugar levels quality 25 mg acarbose. Alendronate is available in oral formulations for once-daily or once-weekly administration. Ibandronate and risedronate are both indicated for the prevention and treatment of osteoporosis in postmenopausal women. Risedronate is also approved for osteoporosis in men as well as for treatment of glucocorticoid-induced osteoporosis. Ibandronate is formulated for once-monthly oral administration, whereas risedronate formulations are available for daily, weekly, or monthly oral administration. Alendronate, pamidronate, and risedronate are also approved for the treatment of Paget disease of bone. Before treatment, imaging and laboratory studies usually show evidence of increased bone turnover (remodeling), bone hypertrophy, and abnormal bone structure. By inhibiting abnormal osteoclast activity in patients with this disease, the bisphosphonates help to normalize biochemical indices of bone remodeling and restore normal bone structure. Patients who are symptomatic or who require orthopedic surgery are candidates for bisphosphonate therapy. If a relapse occurs, another course of treatment can be given after a 6-month interval. In patients with bone cancer, bisphosphonates are useful in the management of osteolytic bone disease and resulting hypercalcemia. Intravenous administration of pamidronate or zoledronic acid is the most effective treatment for hypercalcemia associated with cancer. Bisphosphonate treatment inhibits bone resorption, reduces the tumor burden in bone, decreases bone pain, and reduces the risk of fractures in patients whose cancer has metastasized to bone. The skeletal effects of teriparatide depend on the frequency and duration of administration. Daily subcutaneous administration of teriparatide for up to 2 years stimulates bone formation on trabecular and cortical bone surfaces by preferentially stimulating osteoblastic activity more than osteoclastic activity. Teriparatide increases markers of bone formation, skeletal mass, and bone strength. Teriparatide is indicated for the treatment of postmenopausal women with osteoporosis who are at high risk for bone fracture. These include women with a history of osteoporotic fracture, women who have multiple risk factors for fracture, and women who are intolerant of other therapy. Teriparatide is also used to increase bone mass in hypogonadal men with a high risk of fracture, such as those receiving gonadotropin-releasing hormone therapy for prostate cancer. Cessation of teriparatide therapy may be followed by a rapid loss of bone, and teriparatide should be followed by a bisphosphonate or other antiresorptive agent. Cinacalcet Cinacalcet is a new drug entity that brings a new mechanism of action for the treatment of hypercalcemia. It works by an agonist action at the calcium-sensing receptor in the parathyroid gland increasing the activation of these calciumsensing receptors to extracellular calcium.

Azelastine is an H1 antihistamine marketed as a nasal spray for the treatment of allergic rhinitis blood glucose needles acarbose 50 mg order overnight delivery. It blocks H1 receptors and inhibits the release of histamine from mast cells, and it is much more potent than either sodium cromoglycate or theophylline in its inhibition. The systemic bioavailability of azelastine after intranasal administration is about 40%, and the plasma half-life is about 22 hours. Azelastine is metabolized by cytochrome P450 enzymes to an active metabolite, desmethylazelastine, a substance whose plasma concentrations are 20% to 30% of azelastine concentrations. Antihistamines are usually more effective when administered before exposure to an allergen than afterward. Hence persons with seasonal allergies, such as allergic rhinitis (see Chapter 27), should take them on a regular basis throughout the allergy season. Pharmacologic Effects and Indications the H1 antihistamines are all equally effective in treating allergies, but they differ markedly in their sedative, antiemetic, and anticholinergic properties (Table 26. The second-generation antihistamines cause little or no sedation, so they are often preferred for the treatment of allergies. First-Generation Antihistamines Because the first-generation antihistamines have sedative effects, they are occasionally used to produce sedation. The most sedating antihistamines are diphenhydramine, hydroxyzine, and promethazine. Doxepin has antidepressant and anxiolytic effects, but because of its high affinity for blocking central H1 receptors, it was recently approved at low doses for the treatment of insomnia. Their sedating properties can also be useful in relieving distress caused by the severe pruritus associated with some allergic reactions. Persons taking these drugs should be cautioned against driving or operating machinery. Pheniramine drugs, such as chlorpheniramine, are less sedating than other first-generation drugs and are used primarily in the treatment of allergic reactions to pollen, mold spores, and other environmental allergens. Meclizine is less sedating than diphenhydramine, hydroxyzine, and promethazine, so it is frequently used to prevent motion sickness or treat vertigo. Dimenhydrinate is a mixture of diphenhydramine and 8-chlorotheophylline and is also used for these purposes. Promethazine suppositories are often used to relieve nausea and vomiting associated with various conditions and doxylamine with vitamin B6 (pyridoxine) is used for the treatment of morning sickness in pregnant women (see Chapter 28). The action of ketotifen occurs rapidly, with an effect seen within minutes after administration; because of the noncompetitive nature of the H1 receptor antagonism, it has a longer duration of action than the other agents. It is indicated for the temporary prevention of itching of the eye caused by allergic conjunctivitis. Second-Generation Antihistamines the second-generation drugs lack antiemetic activity, so their use is limited to the treatment of allergies. None of these drugs causes substantial sedation; however, cetirizine is more likely than the other second-generation antihistamines to cause some sedation. Following a common trend in the pharmaceutical industry to market the active enantiomer of racemic drugs already approved, levocetirizine is now also available.

Narrow-spectrum penicillins (penicillin G and penicillin V) are active against many gram-positive cocci diabetes symptoms rashes effective acarbose 25 mg. B, Administration of benzathine penicillin G produces low plasma concentrations of the drug for several weeks. Administration of procaine penicillin G produces higher plasma concentrations for about 24 hours. Probenecid inhibits the renal excretion of penicillin G, prolongs its half-life, and increases its plasma concentrations. Some of the penicillins, such as amoxicillin and penicillin V, are stable in gastric acid and can be given orally, whereas others are acid-labile and must be given parenterally, such as piperacillin. The penicillins are widely distributed to organs and tissues except the central nervous system. Most penicillins are eliminated by active renal tubular secretion and have short half-lives of about 0. The renal tubular secretion of penicillins is inhibited by probenecid, a drug that competes with penicillins for the organic acid transporter located in the proximal tubule. Penicillin G is available in two long-acting forms for intramuscular administration, procaine penicillin G and benzathine penicillin G. Penicillin G is slowly released from these two preparations for absorption into the circulation after an intramuscular injection. Benzathine penicillin G provides very low plasma concentrations of the drug for a few weeks. The narrow-spectrum penicillins, penicillins G and V, are used to treat infections caused by sensitive strains of streptococci (including pneumococci), meningococci, and spirochetes. Penicillin G is also active against Clostridium perfringens, the cause of gas gangrene, and other pathogens. Most staphylococci and gonococci and some strains of pneumococci are now resistant to penicillin G. These penicillins are not active against most other species of penicillinase-producing bacteria. Nafcillin is usually preferred when parenteral administration is required, whereas dicloxacillin can be given orally for less severe infections. The penicillinase-resistant drugs are used to treat serious staphylococcal infections, such as acute endocarditis and osteomyelitis, as well as skin and soft tissue infections. Bacteria resistant to methicillin are also cross-resistant to nafcillin and all other penicillinase-resistant penicillins. Amoxicillin can be used alone to treat respiratory tract infections caused by sensitive bacteria, including otitis media, sinusitis, bronchitis, and communityacquired pneumonia, but some strains of pneumococci (Streptococcus pneumoniae) have developed intermediate resistance to amoxicillin, and larger doses are required to treat infections caused by these organisms. Amoxicillin is also used alone for prophylaxis of bacterial endocarditis in persons with heart valve defects. Formulations of amoxicillin-clavulanate are available to treat respiratory tract infections (pneumonia, sinusitis) caused by these organisms, including a liquid suspension for treating children with otitis media (Box 38.

These benefits were at the expense of an increased rate of procedurerelated adverse events metabolic disease in cats order 25 mg acarbose free shipping. The study was not blinded in that the treating physicians were aware of the study group assignments. LimitationsofCardiac ResynchronizationTherapy the success rate for placement of a transvenous cardiac resynchronization system has ranged from approximately 88% to 92% in clinical trials, although in contemporary clinical experience it is as high as 97% to 98% in some centers. Thus some patients undergoing an implant procedure will not receive a functioning system if this approach is used. Implant-related complications are similar to those seen with standard pacemakers and defibrillators, with the additional risk of dissection or perforation of the coronary sinus. This observation may be important when considering the timing of device placement in eligible patients. This may be due in part to limitations in objective risk assessment in that no invasive or noninvasive testing procedure has been shown to accurately determine which nonischemic heart failure patient is likely to die suddenly. Also clouding the picture were older observations suggesting that the prophylactic administration of an antiarrhythmic agent, amiodarone, might prolong survival in patients with nonischemic cardiomyopathy. Entry criteria included an ejection fraction of 35% or less, a history of symptomatic heart failure, and the presence of ambient arrhythmia defined as an episode of nonsustained ventricular tachycardia or at least 10 premature ventricular contractions per 24-hour period during continuous ambulatory electrocardiographic monitoring. Importantly, the cohort was equally divided between ischemic and nonischemic causes of heart failure, thereby allowing an important subgroup analysis of these cohorts to be done. Such information may be useful in Finally, a new generation of even more sophisticated implantable evaluating heart failure clinical status and/or in predicting episodes monitoring devices is under investigation. If these devices are reliable in the tinuous or intermittent assessment of hemodynamics, generally latter sense, use of this information may improve heart failure outfocused on assessment of intracardiac or pulmonary artery pressure. The activity level may serve as a useful teaching addition to standard of care (treatment group; n = 270) versus stanand reinforcement tool to both the patient and family about the dard of care alone (control group; n = 280). Because exercise intolerance is a monary artery pressure monitoring system was used in this trial. Most pressure-based medifailure worsens, this approach to heart failure monitoring may ultication changes (about 75%) involved, as expected, diuretics and mately prove useful. Implantable devices 220 can monitor fluid status by assessing 200 changes in intrathoracic impedance. In a small study of 33 patients, changes in 180 intrathoracic impedance demonstrated 160 the ability to predict hospitalization for 140 decompensated heart failure 10 to 14 days in advance of the event. One of these systems, an implantable left atrial pressure monitoring system, may radically change the way that heart failure patients are chronically managed by promoting a physician-directed, patient self-management paradigm for use. Use of this system is similar to how diabetic individuals self-titrate insulin with the aid of a glucometer. Preliminary data have demonstrated the feasibility and potential usefulness of this approach in patients with heart failure. Substantial experience suggests that it is safe and effective, with patients demonstrating significant improvement in both clinical symptoms and multiple measures of functional status, exercise capacity, and outcomes. Implantable monitoring technologies have the potential to improve our ability to avoid episodes of heart failure decompensation and may improve the natural history of the disease.

25 mg acarbose buy with visa. Diabetes Mellitus Pathophysiology & Nursing | Diabetes Nursing Lecture NCLEX | Type 1 & Type 2.

References